Form 4: Astrana Health Director Receives Stock Grant

Astrana Health, Inc. director Thomas S. Lam was granted restricted stock units and restricted stock, with vesting schedules detailed.

Summary

• Thomas S. Lam, a Director at Astrana Health, Inc., received a grant of 41,667 restricted stock units (RSUs) on April 6, 2026.
• These RSUs vest in eight equal semi-annual installments starting October 6, 2026, contingent upon continued employment.
• Additionally, Mr. Lam's beneficial ownership includes 1,133,706 shares held indirectly through the Thomas and Jeanette Lam 2002 Family Trust.
• He also has indirect beneficial ownership of 6,132,802 shares through Allied Physicians of California, a Professional Medical Corporation, where he holds executive and director roles.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily details a standard equity grant to a director rather than significant financial performance or strategic shifts.

Positives

• Director Thomas S. Lam received a significant grant of restricted stock units, indicating a long-term incentive and alignment with the company's performance.
• The grant of 41,667 RSUs and associated restricted stock demonstrates continued investment in key personnel.
• The vesting schedule for the RSUs and restricted stock is clearly defined, providing transparency for future share acquisition.

Negatives

• The filing details a grant of securities, not a sale, so there are no immediate negative financial implications from this transaction itself.
• The vesting of the RSUs and restricted stock is contingent on continued employment, which represents a potential risk of forfeiture if employment ceases.

Risks

• Vesting of restricted stock units and restricted stock is subject to continuous employment with Astrana Health, Inc. and/or its affiliates.
• The indirect beneficial ownership through Allied Physicians of California and the Thomas and Jeanette Lam 2002 Family Trust means Mr. Lam disclaims beneficial ownership of those shares except to the extent of his pecuniary interest, which could imply a complex ownership structure.

Future Outlook

The future outlook is tied to the vesting of the granted securities, which is dependent on Mr. Lam's continued employment with Astrana Health, Inc. and its affiliates.

Management Comments

• Mr. Lam disclaims beneficial ownership of securities held by Allied Physicians of California, a Professional Medical Corporation, except to the extent of his pecuniary interest therein.
• The inclusion of shares held by Allied Physicians of California is not an admission that Mr. Lam is the beneficial owner for Section 16 or any other purpose.

Industry Context

StockSavvy.ai notes that grants of restricted stock units and restricted stock to directors are common executive compensation practices in the healthcare and technology sectors, aimed at aligning management's interests with those of shareholders and retaining talent.

Related Party Transactions

• The filing indicates indirect beneficial ownership of securities by Thomas S. Lam through Allied Physicians of California, a Professional Medical Corporation, where he holds executive and director roles. This represents a related party transaction due to his influence and interest in the corporation.

Stakeholder Impact

• Shareholders: The grant of RSUs and restricted stock to a director aligns their interests with long-term company performance, potentially benefiting shareholders if the stock price increases.
• Employees: The vesting conditions tied to continued employment may incentivize Mr. Lam to remain with the company, contributing to stability.
• Management: The grant is a form of compensation and incentive for Mr. Lam.

Next Steps

• Vesting of 41,667 restricted stock units will commence on October 6, 2026, in eight semi-annual installments.
• Vesting of restricted stock will commence on March 5, 2027, and April 1, 2027, in two equal annual installments for different tranches.

Key Dates

Keywords

Form 4, SEC Filing, Astrana Health, ASTH, Thomas S. Lam, Director, Restricted Stock Units, RSU, Beneficial Ownership, Stock Grant, Vesting Schedule